With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...

Acellera Therapeutics focuses on drug discovery by merging AI-driven innovation with computational scaleability, aiming to ...

DeepSeek-R1 charts a new path for AI through explaining its own reasoning process. Why does this matter and how will it benefit the world?

AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.

Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process more efficient.

Research co-led by University of Toronto researchers and Insilico Medicine has demonstrated the potential of quantum ...

Over a video call, Alex Zhavoronkov holds up a small, green, diamond-shaped pill. It has been developed by his company to ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

With the use of deep learning and advanced algorithms, generative AI can promote acceleration in the design and development ...

Quantum computing and artificial intelligence (AI) can be combined with classical computing methods to design and discover small-molecule candidates that target the cancer-driving KRAS protein, ...

Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...